Table 1.

Eligibility criteria.

	Inclusion	Exclusion
Participant characteristics	CML diagnosis Aged ≥18 years Males and females Chronic phase Long-term TKI use (i.e. lifelong) Outpatient management Any geographical location	Aged ≤18 years Accelerated/blast phase Receiving end-of-life care Not treated with TKIs Inpatient management
Type of study	Qualitative	Clinical trials/quantitative Systematic reviews Non-English language